J. Herrick, Clinical features of sudden obstruction of the coronary arteries, JAMA LIX, issue.23, pp.2015-2037, 1912.

D. Hasdai, Cardiogenic shock complicating acute coronary syndromes, The Lancet, vol.356, issue.9231, pp.749-56, 2000.
DOI : 10.1016/S0140-6736(00)02640-4

J. Hochman, Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock, New England Journal of Medicine, vol.341, issue.9, pp.625-659, 1999.
DOI : 10.1056/NEJM199908263410901

J. Hochman, Cardiogenic Shock Complicating Acute Myocardial Infarction: Expanding the Paradigm, Circulation, vol.107, issue.24, pp.2998-3002, 2003.
DOI : 10.1161/01.CIR.0000075927.67673.F2

C. Richard, Insuffisance circulatoire aigue

S. Hollenberg, Cardiogenic shock, Ann Intern Med, vol.131, issue.1, pp.41-59, 1999.

H. Guyton, Précis de physiologie médicale, édition Piccin

D. Landry, The Pathogenesis of Vasodilatory Shock, New England Journal of Medicine, vol.345, issue.8, pp.588-95, 2001.
DOI : 10.1056/NEJMra002709

V. Menon, Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry, The American Journal of Medicine, vol.108, issue.5, pp.374-80, 2000.
DOI : 10.1016/S0002-9343(00)00310-7

. Kohsaka, High incidence of sepsis complicating cardiogenic shock following myocardial infarction, Circulation, pp.104-483, 2001.

M. Fink, Bench?to?beside review: cytopathic hypoxia, Critical Care, vol.6, issue.6, pp.491-500, 2002.
DOI : 10.1186/cc1824

V. Borutaité, Rapid reduction of nitric oxide by mitochondria, and reversible inhibition of mitochondrial respiration by nitric oxide, Biochemical Journal, vol.315, issue.1, pp.295-304, 1996.
DOI : 10.1042/bj3150295

A. Cassina, Differential Inhibitory Action of Nitric Oxide and Peroxynitrite on Mitochondrial Electron Transport, Archives of Biochemistry and Biophysics, vol.328, issue.2, pp.309-325, 1996.
DOI : 10.1006/abbi.1996.0178

Y. Takehara, Oxygen-Dependent Regulation of Mitochondrial Energy Metabolism by Nitric Oxide, Archives of Biochemistry and Biophysics, vol.323, issue.1, pp.27-32, 1995.
DOI : 10.1006/abbi.1995.0005

M. Nishikawa, Role of glutathione and nitric oxide in the energy metabolism of rat liver mitochondria, FEBS Letters, vol.382, issue.3, pp.341-346, 1997.
DOI : 10.1016/0014-5793(96)00086-5

J. Torres, Inhibition of cytochrome c oxidase in turnover by nitric oxide: mechanism and implications for control of respiration, Biochemical Journal, vol.312, issue.1, pp.169-73, 1995.
DOI : 10.1042/bj3120169

A. Giuffre, Oxidase by Nitric Oxide, Journal of Biological Chemistry, vol.247, issue.52, pp.33404-33412, 2000.
DOI : 10.1016/0014-5793(95)00763-Y

G. Brown, Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration, Neuroscience Letters, vol.193, issue.3, pp.201-205, 1995.
DOI : 10.1016/0304-3940(95)11703-Y

R. Radi, Inhibition of Mitochondrial Electron Transport by Peroxynitrite, Archives of Biochemistry and Biophysics, vol.308, issue.1, pp.96-102, 1994.
DOI : 10.1006/abbi.1994.1013

E. Braunwald and R. Kloner, Myocardial reperfusion: a double-edged sword?, Journal of Clinical Investigation, vol.76, issue.5, pp.1713-1722, 1985.
DOI : 10.1172/JCI112160

D. Ku, Coronary vascular reactivity after acute myocardial ischemia, Science, vol.218, issue.4572, pp.576-584, 1982.
DOI : 10.1126/science.7123259

A. Moens, Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process, International Journal of Cardiology, vol.100, issue.2, pp.179-90, 2005.
DOI : 10.1016/j.ijcard.2004.04.013

S. Javadov and M. Karmazyn, Mitochondrial Permeability Transition Pore Opening as an Endpoint to Initiate Cell Death and as a Putative Target for Cardioprotection, Cellular Physiology and Biochemistry, vol.110, issue.1-4, pp.1-22, 2007.
DOI : 10.1016/j.bbadis.2005.06.003

M. Crompton, The mitochondrial permeability transition pore and its role in cell death, Biochemical Journal, vol.341, issue.2, pp.233-282, 1999.
DOI : 10.1042/bj3410233

D. Lisa and F. , and Is a Causative Event in the Death of Myocytes in Postischemic Reperfusion of the Heart, Journal of Biological Chemistry, vol.231, issue.4, pp.2571-2576, 2001.
DOI : 10.1016/S0006-3495(99)77239-5

C. Adrie, Postresuscitation disease after cardiac arrest: a sepsis-like syndrome?, Current Opinion in Critical Care, vol.10, issue.3, pp.208-220, 2004.
DOI : 10.1097/01.ccx.0000126090.06275.fe

C. Adrie, Successful Cardiopulmonary Resuscitation After Cardiac Arrest as a "Sepsis-Like" Syndrome, Circulation, vol.106, issue.5, pp.562-570, 2002.
DOI : 10.1161/01.CIR.0000023891.80661.AD

S. Gando, Out-of-hospital cardiac arrest increases soluble vascular endothelial adhesion molecules and neutrophil elastase associated with endothelial injury, Intensive Care Medicine, vol.26, issue.1, pp.38-44, 2000.
DOI : 10.1007/s001340050009

R. Munford, Normal Responses to Injury Prevent Systemic Inflammation and Can Be Immunosuppressive, American Journal of Respiratory and Critical Care Medicine, vol.7, issue.2, pp.316-337, 2001.
DOI : 10.1056/NEJM199108293250903

I. Laurent, Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest, Journal of the American College of Cardiology, vol.40, issue.12, pp.2110-2116, 2002.
DOI : 10.1016/S0735-1097(02)02594-9

C. Spaulding, Immediate Coronary Angiography in Survivors of Out-of-Hospital Cardiac Arrest, New England Journal of Medicine, vol.336, issue.23, pp.1629-1662, 1997.
DOI : 10.1056/NEJM199706053362302

C. Adrie, Coagulopathy After Successful Cardiopulmonary Resuscitation Following Cardiac Arrest, Journal of the American College of Cardiology, vol.46, issue.1, pp.21-29, 2005.
DOI : 10.1016/j.jacc.2005.03.046

URL : https://doi.org/10.1016/j.jacc.2005.03.046

R. Goldberg, Temporal Trends in Cardiogenic Shock Complicating Acute Myocardial Infarction, New England Journal of Medicine, vol.340, issue.15, pp.1162-1170, 1999.
DOI : 10.1056/NEJM199904153401504

R. Goldberg, Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction: A Population-Based Perspective, Circulation, vol.119, issue.9, pp.1211-1230, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.814947

G. The, An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction, N Engl J Med, vol.329, pp.673-82, 1993.

D. Holmes, Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience, Journal of the American College of Cardiology, vol.26, issue.3, pp.668-74, 1995.
DOI : 10.1016/0735-1097(95)00215-P

J. Hochman, Early Revascularization and Long-term Survival in Cardiogenic Shock Complicating Acute Myocardial Infarction, JAMA, vol.295, issue.21, pp.2511-2516, 2006.
DOI : 10.1001/jama.295.21.2511

A. Babaev, Trends in Management and Outcomes of Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock, JAMA, vol.294, issue.4, pp.448-54, 2005.
DOI : 10.1001/jama.294.4.448

K. Fox, Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006, JAMA, vol.297, issue.17, pp.1892-1900, 2007.
DOI : 10.1001/jama.297.17.1892

D. Holmes, Cardiogenic Shock in Patients With Acute Ischemic Syndromes With and Without ST-Segment Elevation, Circulation, vol.100, issue.20, pp.2067-73, 1999.
DOI : 10.1161/01.CIR.100.20.2067

D. Holmes, Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial, The Lancet, vol.349, issue.9045, pp.75-83, 1997.
DOI : 10.1016/S0140-6736(96)03031-0

C. Torgersen, Hemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study, Critical Care, vol.13, issue.5, p.157, 2009.
DOI : 10.1186/cc8114

S. Mollema, Prognostic value of echocardiography after acute myocardial infarction, Heart, vol.95, issue.21, pp.1732-1777, 2009.
DOI : 10.1136/hrt.2008.161836

D. Hasdai, Cardiogenic shock complicating acute myocardial infarction: Predictors of death, American Heart Journal, vol.138, issue.1, pp.21-31, 1999.
DOI : 10.1016/S0002-8703(99)70241-3

L. Sleeper, A severity scoring system for risk assessment of patients with cardiogenic shock: A report from the SHOCK Trial and Registry, American Heart Journal, vol.160, issue.3, pp.443-50, 2010.
DOI : 10.1016/j.ahj.2010.06.024

L. Tan and W. Littler, Measurement of cardiac reserve in cardiogenic shock: implications for prognosis and management., Heart, vol.64, issue.2, pp.121-129, 1990.
DOI : 10.1136/hrt.64.2.121

R. Fincke, Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry, Journal of the American College of Cardiology, vol.44, issue.2, pp.340-348, 2004.
DOI : 10.1016/j.jacc.2004.03.060

M. Hamon, Prognostic impact of right ventricular involvement in patients with acute myocardial infarction: Meta-analysis, Critical Care Medicine, vol.36, issue.7, pp.2023-2056, 2008.
DOI : 10.1097/CCM.0b013e31817d213d

A. Engström, Right ventricular dysfunction is an independent predictor for mortality in ST-elevation myocardial infarction patients presenting with cardiogenic shock on admission, European Journal of Heart Failure, vol.261, issue.3, pp.276-82, 2010.
DOI : 10.1002/ar.1091360304

S. Hollenberg, Vasoactive Drugs in Circulatory Shock, American Journal of Respiratory and Critical Care Medicine, vol.183, issue.7, pp.847-55, 2011.
DOI : 10.1097/01.CCM.0000230244.17174.4F

P. Desjars, Norepinephrine therapy has no deleterious renal effects in human septic shock, Critical Care Medicine, vol.17, issue.5, pp.426-435, 1989.
DOI : 10.1097/00003246-198905000-00010

C. Martin, Septic shock: a goal-directed therapy using volume loading, dobutamine and/or norepinephrine, Acta Anaesthesiologica Scandinavica, vol.23, issue.5, pp.413-420, 1990.
DOI : 10.1161/01.CIR.34.2.260

W. Schreuder, Effect of Dopamine vs Norepinephrine on Hemodynamics in Septic Shock, Chest, vol.95, issue.6, pp.1282-1290, 1989.
DOI : 10.1378/chest.95.6.1282

P. Marik, The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hemodynamic sepsis, JAMA, vol.271, pp.1354-1361, 1994.

C. Martin, Renal effects of norepinephrine used to treat septic shock patients, Critical Care Medicine, vol.18, issue.3, pp.282-287, 1990.
DOI : 10.1097/00003246-199003000-00007

E. Redl?wenzl, The effects of norepinephrine on hemodynamics and renal function in severe septic shock states, Intensive Care Medicine, vol.18, issue.3, pp.151-155, 1993.
DOI : 10.1007/BF01720530

E. Ruokonen, Regional blood flow and oxygen transport in septic shock, Critical Care Medicine, vol.21, issue.9, pp.1296-303, 1993.
DOI : 10.1097/00003246-199309000-00011

C. Martin, Norepinephrine or Dopamine for the Treatment of Hyperdynamic Septic Shock?, Chest, vol.103, issue.6, pp.1826-1857, 1993.
DOI : 10.1378/chest.103.6.1826

B. Levy, Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study, Intensive Care Medicine, vol.23, issue.3, pp.282-289, 1997.
DOI : 10.1007/s001340050329

C. Martin, Effect of norepinephrine on the outcome of septic shock, Critical Care Medicine, vol.28, issue.8, pp.2758-65, 2000.
DOI : 10.1097/00003246-200008000-00012

D. Backer and D. , Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: Which is best?*, Critical Care Medicine, vol.31, issue.6, pp.1659-67, 2003.
DOI : 10.1097/01.CCM.0000063045.77339.B6

D. Backer and D. , Comparison of Dopamine and Norepinephrine in the Treatment of Shock, New England Journal of Medicine, vol.362, issue.9, pp.779-89, 2010.
DOI : 10.1056/NEJMoa0907118

K. Hoogenberg, Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers, Critical Care Medicine, vol.26, issue.2, pp.260-265, 1998.
DOI : 10.1097/00003246-199802000-00022

DOI : 10.1097/01.shk.0000150549.45338.6c

URL : https://hal.archives-ouvertes.fr/inserm-00388771

R. Bellomo, Low?dose dopamine in patients with early renal dysfunction: a placebo? controlled randomized trial, Lancet, vol.356, pp.2139-2182, 2000.

G. Van-den-berghe, Anterior pituitary function during critical illness and dopamine treatment, Critical Care Medicine, vol.24, issue.9, pp.1580-90, 1996.
DOI : 10.1097/00003246-199609000-00024

R. Oberbeck, Dopamine affects cellular immune functions during polymicrobial sepsis, Intensive Care Medicine, vol.279, issue.26, pp.731-740, 2006.
DOI : 10.1016/S0039-6060(99)70171-6

Y. Sakr, Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study*, Critical Care Medicine, vol.34, issue.3, pp.589-97, 2006.
DOI : 10.1097/01.CCM.0000201896.45809.E3

P. Povoa, Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study)*, Critical Care Medicine, vol.37, issue.2, pp.410-416, 2009.
DOI : 10.1097/CCM.0b013e3181958b1c

J. Myburgh, A comparison of epinephrine and norepinephrine in critically ill patients, Intensive Care Medicine, vol.365, issue.12, pp.2226-2260, 2008.
DOI : 10.1097/00003246-199811000-00016

D. Annane, Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial, The Lancet, vol.370, issue.9588, pp.676-84, 2007.
DOI : 10.1016/S0140-6736(07)61344-0

B. Levy, Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study*, Critical Care Medicine, vol.39, issue.3, pp.450-455, 2011.
DOI : 10.1097/CCM.0b013e3181ffe0eb

. J. Lipman, Vasoconstrictor effect of adrenaline in human septic shock, Anaesth Intensive Care, vol.19, pp.61-66, 1991.

W. Wilson, Septic shock: does adrenaline have a role as first?line inotropic agent?, Anaesth Intensive Care, vol.20, pp.470-474, 1992.

J. Moran, Epinephrine as an inotropic agent in septic shock, Critical Care Medicine, vol.21, issue.1, pp.70-77, 1993.
DOI : 10.1097/00003246-199301000-00015

S. Mackenzie, Adrenaline in treatment of septic shock: Effects on haemodynamics and oxygen transport, Intensive Care Medicine, vol.94, issue.Suppl I, pp.36-45, 1991.
DOI : 10.1164/arrd.1986.134.5.873

L. Tulzo and Y. , Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: a preliminary descriptive study, Intensive Care Medicine, vol.23, issue.6, pp.664-70, 1997.
DOI : 10.1007/s001340050391

N. Day, The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection, The Lancet, vol.348, issue.9022, pp.219-242, 1996.
DOI : 10.1016/S0140-6736(96)09096-4

A. Meier?hellmann, Epinephrine impairs splanchnic perfusion in septic shock, Critical Care Medicine, vol.25, issue.3, pp.399-404, 1997.
DOI : 10.1097/00003246-199703000-00005

S. Zhou, Effects of norepinephrine, epinephrine, and ?norepinephrine?dobutamine on systemic and gastric mucosal oxygenation in septic shock, Acta Pharmacol Sin, vol.23, pp.654-662, 2002.

T. Martikainen, content gradients and lactate-to-pyruvate ratios, American Journal of Physiology-Gastrointestinal and Liver Physiology, vol.288, issue.3, pp.586-92, 2005.
DOI : 10.1213/01.ANE.0000072703.37396.93

P. Seguin, Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock, Clinical Pharmacology & Therapeutics, vol.71, issue.5, pp.381-389, 2002.
DOI : 10.1067/mcp.2002.122471

P. Seguin, Dopexamine and norepinephrine versus epinephrine on gastric perfusion in patients with septic shock: a randomized study, Critical Care, vol.10, issue.1, p.32, 2006.
DOI : 10.1186/cc4827

URL : https://hal.archives-ouvertes.fr/inserm-00081456

R. Neviere, Dobutamine improves gastrointestinal mucosal blood flow in a porcine model of endotoxic shock, Critical Care Medicine, vol.25, issue.8, pp.1371-1378, 1997.
DOI : 10.1097/00003246-199708000-00026

M. Russ, Hemodynamic improvement following lévosimendan treatment in patients with acute myocardial infarction and cardiogenic shock, Crit Care Med, vol.35, pp.2732-2741, 2007.

M. Garcia?gonzalez, Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics, European Journal of Heart Failure, vol.79, issue.Suppl I, pp.723-731, 2006.
DOI : 10.1172/JCI108178

F. Follath, Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial, The Lancet, vol.360, issue.9328, pp.196-202, 2002.
DOI : 10.1016/S0140-6736(02)09455-2

A. Mebazaa, Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure, JAMA, vol.297, issue.17, pp.1883-91, 2007.
DOI : 10.1001/jama.297.17.1883

A. Morelli, Effects of lévosimendan on systemic and regional hemodynamics in septic myocardial depression. Intens Care Med, pp.638-682, 2005.

A. Morelli, Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: A pilot study*, Critical Care Medicine, vol.34, issue.9, pp.2287-93, 2006.
DOI : 10.1097/01.CCM.0000230244.17174.4F

J. Fuhrmann, Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction*, Critical Care Medicine, vol.36, issue.8, pp.2257-66, 2008.
DOI : 10.1097/CCM.0b013e3181809846

S. Naidu, Novel Percutaneous Cardiac Assist Devices: The Science of and Indications for Hemodynamic Support, Circulation, vol.123, issue.5, pp.533-576, 2011.
DOI : 10.1161/CIRCULATIONAHA.110.945055

A. Kantrowitz, Initial Clinical Experience With Intraaortic Balloon Pumping in Cardiogenic Shock, JAMA: The Journal of the American Medical Association, vol.203, issue.2, pp.113-121, 1968.
DOI : 10.1001/jama.1968.03140020041011

S. Scheidt, Intra-Aortic Balloon Counterpulsation in Cardiogenic Shock, New England Journal of Medicine, vol.288, issue.19, pp.979-84, 1973.
DOI : 10.1056/NEJM197305102881901

K. Sjauw, A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?, European Heart Journal, vol.26, issue.13, pp.459-68, 2009.
DOI : 10.1093/eurheartj/ehi161

S. Marasco, Review of ECMO (Extra Corporeal Membrane Oxygenation) Support in Critically Ill Adult Patients, Heart, Lung and Circulation, vol.17, pp.41-48, 2008.
DOI : 10.1016/j.hlc.2008.08.009

D. Sidebotham, Extracorporeal membrane oxygenation for treating severe cardiac and respiratory failure in adults Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years Doll N et al. Five?year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock Combes A et al. Outcomes and long?term quality of life of patients supported by extracorporeal Membrane oxygenation for cardiogenic shock, J Cardiothorac Vasc Anesth J Thorac Cardiovasc Surg Ann Thorac Surg Crit Care Med, vol.23, issue.36, pp.886-92, 2001.

M. Mirabel, Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support*, 1421?7 105. Recommandations sur les indications de l'assistance circulatoire dans le traitement des arrêts cardiaques réfractaires, pp.1029-1064, 2001.
DOI : 10.1097/CCM.0b013e31820ead45